Jaktinib Hydrochloride Cream For Atopic Dermatitis
Clinical trial NCT04435392 · COMPLETED
Trial details
- NCT number
- NCT04435392
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2022-09-08
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.